Virus oncogénicos y vías de señalización alteradas en cáncer. Interacciones de oncoproteínas de VPH y proteínas celulares que participan en procesos de transformación. Participación de VPH en regulación transcripcional. Epidemiología y aspectos funcionales de variantes de VPH.

Publicaciones

1. Torres-Poveda K, Piña-Sánchez P, Vallejo-Ruiz V, Lizano M, Cruz-Valdez A, Juárez-Sánchez P, Garza-Salazar J, Manzo-Merino J. Molecular markers for the diagnosis of high-risk human papillomavirus infection and triage of human papillomavirus-positive women. Rev Invest Clin 2020;72(4):198-212. I.F.: 1.513.

2. Morales-Garcia V, Contreras-Paredes A, Martinez-Abundis E, Gomez-Crisostomo NP, Lizano M, Hernandez-Landero F, de la Cruz-Hernandez E. The high-Risk HPV E6 proteins modify the activity of the eIF4E protein via the MEK/ERK and AKT/PKB pathways. FEBS Open Bio 2020. I.F.: 2.79.

3. Ayala-Domínguez L, Pérez-Cárdenas E, Avilés-Salas A, Medina LA, Lizano M (corresponding author), Brandan ME (corresponding author). Quantitative Imaging Parameters of Contrast-Enhanced Micro-Computed Tomography Correlate with Angiogenesis and Necrosis in a Subcutaneous C6 Glioma Model. Cancers (Basel). 2020 Nov 18;12(11):3417. I.F.: 6.639.

4. Olmedo-Nieva L, Muñoz-Bello JO, Manzo-Merino J, Lizano M (corresponding author). New insights in Hippo signalling alteration in human papillomavirus-related cancers. Cell Signal. 2020 Dec;76:109815. I.F.: 5.712.

5. Ortiz-Pedraza Y, Muñoz-Bello JO, Olmedo-Nieva L, Contreras-Paredes A, Martínez-Ramírez I, Langley E, Lizano M (corresponding author). Non-Coding RNAs as Key Regulators of Glutaminolysis in Cancer. Int J Mol Sci 2020;21(8):2872. I.F.: 4.556.

6. Meza-Menchaca T, Lizano-Soberón M, Trigos A, Zepeda RC, Medina ME, Galindo-Murillo R. Elucidating Molecular Interactions of Ten Natural Compounds Targeting E6 HPV High Risk Oncoproteins Using Microsecond Molecular Dynamics Simulations. Med Chem 2021; 17(6):587-600. I.F.: 2.745.

7. Morán-Torres A, Pazos-Salazar NG, Téllez-Lorenzo S, Jiménez-Lima R, Lizano M, Reyes-Hernández DO, Marin-Aquino JJ, Manzo-Merino J. HPV oral and oropharynx infection dynamics in young population. Braz J Microbiol. 2021;52(4):1991-2000. . I.F.:2.21

8. Díaz-Tejeda Y, Guido-Jiménez MC, López-Carbajal H, Amador-Molina A, Méndez-Martínez R, Gariglio-Vidal P, Lizano M (corresponding author), García Carrancá A (corresponding author). Nanog, in Cooperation with AP1, Increases the Expression of E6/E7 Oncogenes from HPV Types 16/18. Viruses 2021; 13:1482. I.F.: 4.7

9. Rojas-Ochoa A, Córdova EJ, Carrillo-García A, Lizano M, Pedraza-Chaverri J, Patiño N, Cruz-Gregorio A, Osnaya N. The Polyphenols a-Manostin and Nordihydroguaiaretic Acid Oxidative Stress, Cell Cycle Arrest and Apoptosis in a Cellular Model of Meduloblastoma. Molecules. 2021;26(23):7230. I.F.: 4.412.

10. Segura-Villalobos D, Ramírez-Moreno IG, Martínez-Aguilar M, Ibarra-Sánchez A, Muñoz-Bello JO, Anaya-Rubio I, Padilla A, Macías-Silva M, Lizano M, González-Espinosa C. Mast Cell-Tumor Interactions: Molecular Mechanisms of Recruitment, Intratumoral Communication and Potential Therapeutic Targets for Tumor Growth. Cells. 2022. 20;11(3):349. I.F.: 7.66.

11. Muñoz-Bello JO, Carrillo-García A, Lizano M (corresponding author). Epidemiology and Molecular Biology of HPV Variants in Cervical Cancer: The State of the Art in Mexico. Int J Mol Sci. 2022; 23(15):8566. I.F.: 6.208.

12. Vázquez-Ulloa E, Lin KL, Lizano M, Sahlgren C. Reversible and bidirectional signaling of notch ligands. Crit Rev Biochem Mol Biol. 2022; 57(4):377-398. I.F.: 8.276

13. Belman-Rodriguez C, Sengar P, Hirata GA, Manzo-Merino J, Lizano M, Farías MH, Aguila SA. Synthesis and optimization of photothermal properties of NIR emitting LiGa5O8: Cr3+ and gold nanorods as hybrid materials for theranostic applications.
Transl Oncol. 2023; 27:101584. I.F.: 4.243.

14. Castro-Muñoz LJ, Rocha-Zavaleta L, Lizano M, Ramírez-Alcántara KM, Madrid-Marina V, Manzo-Merino J. Alteration of the IFN-Pathway by Human Papillomavirus Proteins: Antiviral Immune Response Evasion Mechanism. Biomedicines. 2022; 10(11):2965. I.F.: 5.225.

15. Olmedo-Nieva L, Muñoz-Bello JO, Martínez-Ramírez I, Martínez-Gutiérrez AD, Ortiz-Pedraza Y, González-Espinosa C, Madrid-Marina V, Torres-Poveda K, Bahena-Roman M, Lizano M (correponding author). RIPOR2 Expression Decreased by HPV-16 E6 and E7 Oncoproteins: An Opportunity in the Search for Prognostic Biomarkers in Cervical Cancer. Cells. 2022; 11(23):3942. I.F.: 7.66.

16. Reyes-Hernández DO, Morán-Torres A, Jimenez-Lima R, Cano-Valdez AM, Cortés-González CC, Castro-Muñoz LJ, Olmedo-Nieva L, Maldonado-Frías S, Pazos-Salazar NG, de Jesús Marín-Aquíno J, García-Carrancá A, Carrillo-García A, Muñoz-Bello JO, *Lizano M (corresponding author), *Manzo-Merino J (corresponding author). HPV Prevalence and Predictive Biomarkers for Oropharyngeal Squamous Cell Carcinoma in Mexican Patients. Pathogens. 2022; 13;11(12):1527. I.F.:3.492.

17. Castro-Muñoz LJ, Ulloa EV, Sahlgren C, Lizano M, De La Cruz-Hernández E, Contreras-Paredes A. Modulating epigenetic modifications for cancer therapy (Review).
Oncol Rep. 2023 Mar;49(3):59. I.F.: 3.906.

18. Ortiz-Pedraza Y, Muñoz-Bello JO, Ramos-Chávez LA, Martínez-Ramírez I, Olmedo-Nieva L, Manzo-Merino J, López-Saavedra A, Pérez-de la Cruz V, Lizano M (corresponding author). HPV16 E6 and E7 Oncoproteins Stimulate the Glutamine Pathway Maintaining Cell Proliferation in a SNAT1-Dependent Fashion. Viruses. 2023; 24;15(2):324. I.F.: 5.818.

19. Martínez-Aguilar LM, Ibarra-Sánchez A, Guerrero-Morán DJ, Macías-Silva M, Muñoz-Bello JO, Padilla A, Lizano M, González-Espinosa C. Lysophosphatidylinositol Promotes Chemotaxis and Cytokine Synthesis in Mast Cells with Differential Participation of GPR55 and CB2 Receptors. Int J Mol Sci. 2023; 28;24 (7):6316. I.F.: 6.628.

20. Ayala-Dominguez L, Medina LA, Aceves C, Lizano M, Brandan ME. Accuracy and Precision of Iodine Quantification in Subtracted Micro-Computed Tomography: Effect of Reconstruction and Noise Removal Algorithms. Mol Imaging Biol. 2023 25(6):1084-1093. I.F.:3.488.

21. López-Méndez JA, Ventura-Gallegos JL, Camacho-Arroyo I, Lizano M, Cabrera-Quintero AJ, Romero-Córdoba SL, Martínez-Vázquez M, Jacobo-Herrera NJ, León-Del-Río A, Paredes-Villa AA, Zentella-Dehesa A. The inhibitory effect of trastuzumab on BT474 triple‑positive breast cancer cell viability is reversed by the combination of progesterone and estradiol. Oncol Lett. 2023;27(1):19. I.F.: 3.11.

22. Ponce-de-Leon S, Lizano M (corresponding author). Harnessing the post-vaccination era: Do emerging HPV types represent a new threat? Cell Host Microbe. 2023 Nov 8;31(11):1774-1775. I.F.:31.316.

23. Sánchez D, Cesarman-Maus G, Romero L, Sánchez-Verin R, Vail D, Guadarrama M, Pelayo R, Sarmiento-Silva RE, Lizano M (corresponding author) . The NDV-MLS as an Immunotherapeutic Strategy for Breast Cancer: Proof of Concept in Female Companion Dogs with Spontaneous Mammary Cancer. Viruses. 2024;16(3):372. I.F.: 4.8.

24. Vallejo-Ruiz V, Gutiérrez-Xicotencatl L, Medina-Contreras O, Lizano M (corresponding author). Molecular aspects of cervical cancer: a pathogenesis update. Front Oncol. 2024;14:1356581. I.F.: 4.7.

25. Promising predictive molecular biomarkers for cervical cancer (Review). Lizano M, Carrillo-García A, De La Cruz-Hernández E, Castro-Muñoz LJ, Contreras-Paredes A. Int J Mol Med. 2024;53(6):50. I.F.: 5.314.

26. Duenas-Gonzalez A, Gonzalez-Fierro A, Bornstein-Quevedo L, Gutierrez-Delgado F, Kast RE, Chavez-Blanco A, Dominguez-Gomez G, Candelaria M, Romo-Pérez A, Correa-Basurto J, Lizano M, Perez-de la Cruz V, Robles-Bañuelos B, Nuñez-Corona D, Martinez-Perez E, Verastegui E.Multitargeted polypharmacotherapy for cancer treatment. theoretical concepts and proposals. Expert Rev Anticancer Ther. 2024;24(8):665-677.

27. Muñoz-Bello JO, Romero-Córdoba SL, García-Chávez JN, González-Espinosa C, Langley E, Lizano M (corresponding author). Potential Transcript-Based Biomarkers Predicting Clinical Outcomes of HPV-Positive Head and Neck Squamous Cell Carcinoma Patients. Cells. 2024;13(13):1107.

28. Márquez-Mendoza JM, Baranda-Ávila N, Lizano M, Langley E. Micro-RNAs targeting the estrogen receptor alpha involved in endocrine therapy resistance in breast cancer.
Biochim Biophys Acta Mol Basis Dis. 2025 1871(5):167783.

29. García-Chávez JN, Contreras-Paredes A, González-Espinosa C, Martínez-Ramírez I, Langley E, Lizano M (correponding author), Muñoz-Bello JO (correspoding author).
Association of Gene Expression Profiles in HPV-Positive Head and Neck Squamous Cell Carcinoma with Patient Outcome: In Search of Prognostic Biomarkers. Int J Mol Sci. 2025;26(12):5894

Circuito de Posgrado, Ciudad Universitaria
Alcaldía Coyoacán, C.P. 04510, México, CDMX

55 5623 7006
mdcbq@posgrado.unam.mx